These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22835002)

  • 1. Life-threatening coma and full-thickness sunburn in a patient treated with transdermal fentanyl patches: a case report.
    Sindali K; Sherry K; Sen S; Dheansa B
    J Med Case Rep; 2012 Jul; 6():220. PubMed ID: 22835002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misuse of fentanyl transdermal patch mixed with acute coronary syndrome.
    Kucuk HO; Kucuk U; Kolcu Z; Balta S; Demirkol S
    Hum Exp Toxicol; 2016 Jan; 35(1):51-2. PubMed ID: 25736329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
    Jackson LD; Wortzman R; Chua D; Selby D
    J Oncol Pharm Pract; 2021 Jan; 27(1):238-243. PubMed ID: 32501183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
    Muijsers RB; Wagstaff AJ
    Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA; Santiago-Palma J; Moryl N; Payne R; Obbens EA
    Drug Saf; 2003; 26(13):951-73. PubMed ID: 14583070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death in Sauna Associated With a Transdermal Fentanyl Patch.
    Kriikku P; Ojanperä I; Lunetta P
    Am J Forensic Med Pathol; 2020 Dec; 41(4):313-314. PubMed ID: 32740103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal fentanyl: pharmacology and toxicology.
    Nelson L; Schwaner R
    J Med Toxicol; 2009 Dec; 5(4):230-41. PubMed ID: 19876859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal misuse of transdermal fentanyl patches.
    Geile J; Maas A; Kraemer M; Doberentz E; Madea B
    Forensic Sci Int; 2019 Sep; 302():109858. PubMed ID: 31279508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl patches: preventable overdose.
    Prescrire Int; 2010 Feb; 19(105):22-5. PubMed ID: 20455338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fatal Case of Poisoning with Fentanyl Transdermal Patches in Japan.
    Nara A; Yamada C; Saka K; Kodama T; Yoshida M; Iwahara K; Takagi T
    J Forensic Sci; 2019 Nov; 64(6):1936-1942. PubMed ID: 31340064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In brief: heat and transdermal fentanyl.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):64. PubMed ID: 19661852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.
    Miyazaki T; Hanaoka K; Namiki A; Ogawa S; Kitajima T; Hosokawa T; Ishida T; Nogami S; Mashimo S
    Clin Drug Investig; 2008; 28(5):313-25. PubMed ID: 18407717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.
    Friesen KJ; Woelk C; Bugden S
    CMAJ; 2016 Jun; 188(9):648-653. PubMed ID: 27044480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not so patchy story of attempted suicide…leading to 24 hours of deep sleep and survival!
    Trist AJ; Sahota H; Williams L
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28096225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch.
    Oliveira G; Hadgraft J; Lane ME
    Toxicol In Vitro; 2012 Jun; 26(4):645-8. PubMed ID: 22405881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A safe and effective method for converting cancer patients from intravenous to transdermal fentanyl.
    Kornick CA; Santiago-Palma J; Khojainova N; Primavera LH; Payne R; Manfredi PL
    Cancer; 2001 Dec; 92(12):3056-61. PubMed ID: 11753984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of oral exposure to fentanyl transdermal delivery system patches.
    Prosser JM; Jones BE; Nelson L
    J Med Toxicol; 2010 Dec; 6(4):443-7. PubMed ID: 20532845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.